Oragenics Inc. (OGEN) is listed on NYSE American in the Manufacturing sector. This page tracks real-time OGEN price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 47.8 Neutral
Market Cap $2.5M
Volume 23.3K
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $-2.2M
EPS $-0.51
P/E Ratio -1.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Telling Fred | Director | Sell | 210 | $0.94 | $197 | 2025 Dec 12 |
| Odyssey Health, Inc. | 10% Owner | Sell | 7,044 | $4.32 | $30,407 | 2025 Jun 18 |
| Odyssey Health, Inc. | 10% Owner | Sell | 10,000 | $4.36 | $43,600 | 2025 Jun 16 |
| Dunton Alan W | Director | Sell | 66 | $0.36 | $24 | 2024 Dec 6 |
| Telling Fred | Director | Sell | 3,597 | $0.36 | $1,295 | 2024 Dec 6 |
| Telling Fred | Director | Sell | 3,500 | $3.57 | $12,495 | 2023 Nov 30 |
| Koski Robert C | Director | Sell | 79,005 | $0.11 | $8,691 | 2022 Dec 30 |
| Koski Robert C | Director | Sell | 165,497 | $0.18 | $29,789 | 2022 Dec 15 |
| Koski Robert C | Director | Sell | 4,503 | $0.18 | $811 | 2022 Dec 14 |
| Koski Robert C | Director | Sell | 48,795 | $0.20 | $9,759 | 2022 Dec 9 |
| Koski Robert C | Director | Sell | 13,036 | $0.20 | $2,607 | 2022 Dec 8 |
| Koski Robert C | Director | Sell | 400,000 | $0.19 | $76,000 | 2022 Nov 30 |
| Telling Fred | Director | Buy | 10,084 | $0.29 | $2,924 | 2022 Jun 17 |
| Telling Fred | Director | Buy | 82,173 | $0.29 | $23,830 | 2022 May 24 |
| Telling Fred | Director | Buy | 65,718 | $0.28 | $18,401 | 2022 May 20 |
| Telling Fred | Director | Buy | 72,109 | $0.28 | $19,884 | 2022 May 19 |
| Telling Fred | Director | Buy | 183,838 | $0.36 | $65,591 | 2022 Mar 31 |
| Sullivan Michael O'Keefe | Interim PEO, CFO | Buy | 20,000 | $0.35 | $7,000 | 2022 Mar 29 |
| Koski Robert C | Director | Buy | 1,000,000 | $0.47 | $465,982 | 2021 Dec 31 |
| Hernandez Joseph | 10% Owner | Sell | 4,200,000 | $0.74 | $3.1M | 2021 Jan 14 |
Take OGEN further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put OGEN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Oragenics Inc. next reports.
Set alerts on OGEN
Get notified when Oragenics Inc. hits your price targets or technical conditions are met.
Get Started Free